作为乳腺癌中与癌症治疗有关的腹泻的治疗,Crofelemer的预期结果。 Promising results for Crofelemer as a treatment for cancer therapy-related diarrhea in breast cancer.

本文重点介绍Crofelemer的可喜结果,这是乳腺癌病人癌症治疗可能造成腹泻的潜在治疗方法。 The article highlights promising results for Crofelemer, a potential treatment for diarrhea caused by cancer therapy in breast cancer patients. 接受在圣安东尼奥乳腺癌专题讨论会上介绍的这些研究结果表明,改进了对这一具有挑战性的副作用的管理。 These findings, accepted for presentation at the San Antonio Breast Cancer Symposium (SABCS), suggest improved management of this challenging side effect. 会上将分享全部研究细节,进一步深入了解克罗费雷默作为治疗选择的有效性。 The full research details will be shared at the conference, offering further insights into Crofelemer's effectiveness as a treatment option.